Cite
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
MLA
Santini, Daniele, et al. “Prognostic Role of Human Equilibrative Transporter 1 (HENT1) in Patients with Resected Gastric Cancer.” Journal of Cellular Physiology, vol. 223, no. 2, May 2010, pp. 384–88. EBSCOhost, https://doi.org/10.1002/jcp.22045.
APA
Santini, D., Vincenzi, B., Fratto, M. E., Perrone, G., Lai, R., Catalano, V., Cass, C., Ruffini, P. A., Spoto, C., Muretto, P., Rizzo, S., Muda, A. O., Mackey, J. R., Russo, A., Tonini, G., & Graziano, F. (2010). Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. Journal of Cellular Physiology, 223(2), 384–388. https://doi.org/10.1002/jcp.22045
Chicago
Santini, Daniele, Bruno Vincenzi, Maria Elisabetta Fratto, Giuseppe Perrone, Raymond Lai, Vincenzo Catalano, Carol Cass, et al. 2010. “Prognostic Role of Human Equilibrative Transporter 1 (HENT1) in Patients with Resected Gastric Cancer.” Journal of Cellular Physiology 223 (2): 384–88. doi:10.1002/jcp.22045.